50,657 Shares of The Clorox Company $CLX Acquired by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. acquired a new stake in The Clorox Company (NYSE:CLX – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor acquired 50,657 shares of the company’s stock, valued at approximately $4,104,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CLX. BlackRock Inc. bought a new position in Clorox during the 2nd quarter worth approximately $958,640,000. Bank of America Corp DE bought a new stake in shares of Clorox in the 2nd quarter valued at approximately $179,780,000. Royal Bank of Canada raised its position in shares of Clorox by 20.1% during the 1st quarter. Royal Bank of Canada now owns 1,418,204 shares of the company’s stock valued at $146,969,000 after acquiring an additional 237,301 shares in the last quarter. ProShare Advisors LLC raised its position in shares of Clorox by 6.3% during the 3rd quarter. ProShare Advisors LLC now owns 1,737,891 shares of the company’s stock valued at $140,787,000 after acquiring an additional 102,732 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in Clorox by 2.3% during the first quarter. Bank of New York Mellon Corp now owns 1,280,226 shares of the company’s stock worth $132,670,000 after purchasing an additional 29,181 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Price Performance

Shares of NYSE CLX traded up $0.10 during midday trading on Friday, reaching $99.80. The company’s stock had a trading volume of 2,387,525 shares, compared to its average volume of 2,530,187. The Clorox Company has a one year low of $79.12 and a one year high of $128.90. The company has a 50 day moving average price of $87.71 and a 200 day moving average price of $99.67. The company has a market cap of $12.07 billion, a price-to-earnings ratio of 17.95, a price-to-earnings-growth ratio of 3.00 and a beta of 0.59. The company has a current ratio of 0.66, a quick ratio of 0.38 and a debt-to-equity ratio of 15.80.

Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Monday, November 2nd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.07 by $0.48. The company had revenue of $1.91 billion during the quarter, compared to analysts’ expectations of $1.88 billion. Clorox had a net margin of 9.41% and a return on equity of 601.88%. The business’s revenue for the quarter was up 33.3% on a year-over-year basis. During the same period last year, the company posted $0.85 earnings per share. On average, equities research analysts expect that The Clorox Company will post 5.76 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Wednesday, October 28th will be paid a $1.25 dividend. The ex-dividend date is Wednesday, October 28th. This represents a $5.00 dividend on an annualized basis and a yield of 5.0%. Clorox’s payout ratio is 89.93%.

Insider Buying and Selling

In other Clorox news, Director Pierre Breber purchased 4,000 shares of the company’s stock in a transaction dated Wednesday, November 4th. The shares were bought at an average price of $100.06 per share, for a total transaction of $400,240.00. Following the purchase, the director directly owned 22,000 shares in the company, valued at $2,201,320. This trade represents a 22.22% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.51% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have weighed in on CLX shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 6th. Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Thursday, October 29th. Jefferies Financial Group lowered shares of Clorox from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $125.00 to $98.00 in a research note on Tuesday, July 28th. Wall Street Zen upgraded Clorox from a “sell” rating to a “hold” rating in a research report on Saturday. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Clorox in a research report on Tuesday. One research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Reduce” and a consensus target price of $93.79.

Read Our Latest Research Report on CLX

About Clorox

(Free Report)

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.